STOPPING at the CAPPP of good HOPE
Author:
Publisher
Oxford University Press (OUP)
Subject
Transplantation,Nephrology
Link
http://academic.oup.com/ndt/article-pdf/15/4/451/23763943/150451.pdf
Reference7 articles.
1. Hanson L, Lindholm L, Niskanen L, et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the captopril prevention project (CAPPP) randomised trial. Lancet1999; 353: 611–616
2. Fournier A, Pruna A, El Esper R et al. Captopril prevention project: what shall we do about captopril and the risk of stroke? Nephrol Dial Transplant2000; 15: 2–5
3. Hannson L, Lindholm LH, Ekbom T et al. For the STOP-Hypertension-2 study group. Randomized trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2 study. Lancet1999; 354: 1751–1756
4. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin converting enzyme inhibitor, ramipril on cardiovascular events in high risk patients. N Engl J Med2000; 342: 145–153
5. Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Study Group. Lancet1998; 351: 1755–1762
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adherence: a major unmet need. CV Success Zone programme;European Heart Journal Supplements;2007-05-01
2. Valsartan in the treatment of hypertension;Aging Health;2005-08
3. The case for blood pressure control in risk groups;International Journal of Clinical Practice;2004-10-20
4. Hypertension therapy: Mixing, matching, and meeting targets;Advances in Therapy;2004-03
5. Recent developments in the treatment of type 2 diabetes mellitus;Cardiovascular Drugs and Therapy;2003
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3